It has also been reported that reduced proliferative capacity, upregulation of inhibitory receptors, such as programmed death 1 (PD-1), and B cell dysfunction are present in cells derived from sarcoidosis patients experiencing disease progression [5–9]. The gene discussed is PDCD1; the disease is sarcoidosis.